Sept. 23, 2026 Small-cap stocks Peraso Inc. (NASDAQ: PRSO), Beneficient (NASDAQ: BENF), Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) and Professional Diversity Network, Inc. (NASDAQ: IPDN) are drawing trader…
Sept. 22, 2026 Four actively traded companies are attracting attention across battery storage, AI infrastructure, insider buying and Arctic energy development: Eos Energy Enterprises, Inc. (NASDAQ: EOSE), DarkHorse Technologies Inc.…
Sept. 22, 2026 VivoSim Labs Inc. (NASDAQ: VIVS) is using engineered human tissues to provide pharmaceutical researchers with earlier and potentially more predictive information about experimental medicines. VivoSim’s 3D biology…
Sept. 21, 2026 Greenland-linked stocks are drawing heightened investor attention following President Donald Trump’s announcement of a new security framework involving the United States, Denmark and Greenland. Described by Trump…
Sept. 18, 2026 Approximately 92% of drugs entering clinical trials fail before receiving regulatory approval, leaving the pharmaceutical industry with a success rate of only about 8%. VivoSim Labs Inc.…
Sept. 17, 2026 Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), VivoSim Labs, Inc. (NASDAQ: VIVS) and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) following developments across AI infrastructure,…
Sept. 15, 2026 Small-cap stocks PDS Biotechnology Corporation (NASDAQ: PDSB), IGC Pharma, Inc. (NYSE: IGC), Peraso Inc. (NASDAQ: PRSO) and ReTo Eco-Solutions, Inc. (NASDAQ: RETO) are in focus following recent…
Sept. 15, 2026 Investors looking across emerging-growth and small-cap stocks are watching Veea Inc. (NASDAQ: VEEA), Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY), DataMEDS AI, Inc. (NASDAQ: MEDS), MySize,…
September 2026 Clifton Mining Company (OTC: CFTN) is gaining attention as elevated gold and silver prices increase investor focus on smaller precious-metals companies with production exposure and established mineral assets.…
September 14, 2026 In drug development, identifying a dangerous compound is only half the challenge. The other is avoiding the premature elimination of a potentially valuable medicine. VivoSim Labs, Inc.…
